Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids: Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity
Author:
Affiliation:
1. Department of Medicinal Chemistry, Metabolic Disorders, Drug Metabolism and Atherosclerosis and Endocrinology, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065-0900
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm050373g
Reference33 articles.
1. Current, New and Future Treatments in Dyslipidaemia and Atherosclerosis
2. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advances in trifluoroethylation reaction;Organic Chemistry Frontiers;2023
2. Visible-light-driven [3 + 2] cyclization of phenols with indoles and olefins using recyclable Ag3PO4 nanoparticles;Green Chemistry;2023
3. Oxidative transformations of olefins employing persulfate/visible light irradiation in water;Organic & Biomolecular Chemistry;2023
4. An Access to Highly Functionalized Dihydrobenzofuran Spirooxindole Scaffolds;Organic Letters;2022-10-14
5. TfOH-Catalyzed [4 + 1] Annulation of p-Quinone Methides with α-Aryl Diazoacetates: Straightforward Access to Highly Functionalized 2,3-Dihydrobenzofurans;The Journal of Organic Chemistry;2021-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3